[Histological Transformation from Non-small Cell Lung Cancer to Small Cell Lung Cancer Induced by Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review] [0.03%]
免疫检查点抑制剂治疗诱发的非小细胞肺癌向小细胞肺癌的组织学转化1例及文献复习
Xiting Chen,Wenyuan He,Ning Yang et al.
Xiting Chen et al.
Non-small cell lung cancer (NSCLC), as the predominant histological subtype of lung cancer, accounts for approximately 85% of all lung cancer cases. In recent years, immune checkpoint inhibitors (ICIs), represented by programmed death 1/pro...
[A Case of Endometrial Metastasis in Lung Adenocarcinoma after EGFR-TKIs Treatment Failure and Literature Review] [0.03%]
[EGFR-TKIs治疗失败后肺癌腺癌子宫内膜转移1例及文献复习]
Fangqian Shen,Zuling Hu,Hua Yang et al.
Fangqian Shen et al.
The incidence and mortality rates of lung cancer remain high, making it the leading cause of cancer-related deaths. In women, the predominant histological subtype is lung adenocarcinoma, commonly associated with epidermal growth factor rece...
[Research Progress on Immunosenescence in Elderly Patients with Advanced Non-small Cell Lung Cancer and Its Immunotherapy] [0.03%]
老年晚期非小细胞肺癌患者免疫衰老的研究进展及其免疫治疗
Na Wang,Yaning Luo,Haoyu Lu et al.
Na Wang et al.
Lung cancer remains the leading cause of cancer-related incidence and mortality worldwide. Among its histological subtypes, non-small cell lung cancer (NSCLC) accounts for the majority of cases, representing the predominant pathological typ...
Daoyun Wang,Zhicheng Huang,Bowen Li et al.
Daoyun Wang et al.
Lung cancer, particularly non-small cell lung cancer (NSCLC), is a leading cause of cancer-related mortality worldwide. In recent years, metabolomics has emerged as a key systems biology approach for analyzing small-molecule metabolites in ...
[Research Progress on the Regulation of Third-generation EGFR-TKIs Resistance in Non-small Cell Lung Cancer by Redox Homeostasis] [0.03%]
第三代EGFR-TKIs耐药非小细胞肺癌的红氧平衡调节研究进展
Ting Luo,Chen Fang,Feng Qiu
Ting Luo
Non-small cell lung cancer (NSCLC) ranks among the most lethal malignancies worldwide. The clinical application of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have successfully revolutionized the treatment paradi...
[Research Progress on the Role of Notch Signaling Pathway in Small Cell Lung Cancer] [0.03%]
notch信号通路在小细胞肺癌中作用的研究进展
Feixue Gu,Kaiyue Zhao,Hengshuo Yan et al.
Feixue Gu et al.
Small cell lung cancer (SCLC), a highly aggressive subtype of lung cancer that originates from pulmonary neuroendocrine cells, accounts for 10% to 15% of all lung cancers. It is characterized by a high rate of early metastasis and extremely...
[Galectin-3 in the Lung Cancer Microenvironment: Immunomodulation and Therapeutic Breakthroughs] [0.03%]
肺癌微环境中半乳糖凝集素3的免疫调控及治疗新突破
Hongbao Zhu,Jiong Deng,Tong Wang
Hongbao Zhu
Lung cancer remains one of the most prevalent and deadly malignancies worldwide, with persistently low five-year survival rates. This poor prognosis is primarily attributed to challenges such as difficulties in early diagnosis, high tumor h...
[Association and Interaction between Multidimensional Lifestyle, Socioeconomic Status and the Incidence of Lung Cancer] [0.03%]
[多维度生活习惯、社会经济状态与肺癌发病率的相关性和交互作用]
Haotian Liu,Runhuang Yang,Haiping Zhang et al.
Haotian Liu et al.
Background: The incidence and mortality rates of lung cancer remain on the rise, creating an urgent need for screening among high-risk populations and early prevention. This study aims to explore the association and inter...
[Application Value of Neoadjuvant Targeted Therapy in Patients with EGFR-mutant Resectable Lung Adenocarcinoma] [0.03%]
可切除肺腺癌患者新辅助靶向治疗的应用价值
Shijie Huang,Mengying Fan,Kaiming Peng et al.
Shijie Huang et al.
Background: The proportion of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is relatively high in China. However, these patients currently lack significant be...
[A Case Report of Coexistence of EGFR and ROS-1 Gene Mutations in Non-small Cell Lung Cancer] [0.03%]
[EGFR和ROS-1基因突变共存的非小细胞肺癌病例报道]
Juan Zhao,Jiaofeng Yu,Ye Fu et al.
Juan Zhao et al.
Lung cancer represents one of the most prevalent malignant tumors globally, and its treatment has entered the era of targeted therapy. The epidermal growth factor receptor (EGFR) mutation is a common type of genetic mutation in non-small ce...